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OBJECTIVES The purpose of this study was to provide clinical and anatomical characteristics as well as
genetic background of a malignant arrhythmogenic disorder.
BACKGROUND An inherited autosomally dominant cardiac syndrome causing stress-induced polymorphic
ventricular tachycardia and syncope in the absence of structural myocardial changes was
detected in two families.
METHODS Two unrelated families with six victims of sudden death and 51 living members were
evaluated. Resting and exercise electrocardiograms (ECG), echocardiography, magnetic
resonance imaging (MRI), cineangiography, microscopic examination of endomyocardial
biopsies and a drug testing with a class IC antiarrhythmic agent flecainide were performed.
A genetic linkage analysis was carried out to map the gene locus.
RESULTS Of the 24 affected individuals, 10 had succumbed with six cases of sudden death, and 14
survivors showed evidence of disease. Exercise stress test induced ventricular bigeminy or
polymorphic ventricular tachycardia in affected individuals. Three children initially examined
before 10 years of age developed arrhythmias during a four-year follow-up. Resting ECGs
were normal in affected subjects except a slight prolongation of the QT intervals adjusted for
heart rate (QTc) (430 6 18 vs. 409 6 19 ms, affected vs. nonaffected, p , 0.01).
Administration of flecainide did not induce ECG abnormalities encountered in familial
idiopathic ventricular fibrillation. Ventricular volumes, contractility and wall measurements
were normal by echocardiography, right ventricular cineangiography and MRI. Histopatho-
logical examination showed no fibrosis or fatty infiltration. The cumulative cardiac mortality
by the age of 30 years was 31%. The disease locus was assigned to chromosome 1q42–q43,
with a maximal pairwise lod score of 4.74 in the two families combined. Only one heterozygous
carrier was clinically unaffected suggesting high disease penetrance in adulthood.
CONCLUSIONS A distinct cardiac disorder linked to chromosome 1q42–q43 causes exercise-induced
polymorphic ventricular tachycardia in structurally normal hearts and is highly malignant.
Delayed clinical manifestation necessitates repeated exercise electrocardiography to assure
diagnosis in young individuals of the families. (J Am Coll Cardiol 1999;34:2035–42) © 1999
by the American College of Cardiology
Inherited arrhythmogenic cardiac disorders such as long QT
syndrome (LQTS) (1), arrhythmogenic right ventricular
dysplasia (ARVD) (2) and dilated or hypertrophic cardio-
myopathies (3) are important causes of syncopal attacks and
sudden death. The congenital LQTS arises from mutations
of at least five different ion channel genes (4), but prolonged
QT interval may also be associated with life-threatening
tachyarrhythmias in cardiomyopathies and acquired heart
diseases. Phenotypically and genetically heterogenic ARVD
is characterized by macroscopic alterations of the right
ventricle and microscopic degenerative changes of the myo-
cardium (5–11). Hypertrophic cardiomyopathy includes ge-
netic variants causing fatal arrhythmias with only subtle
myocardial pathology (3). Thus, a multitude of diagnostic
alternatives should be considered in evaluation of syncopal
episodes of suspected cardiac origin.
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We describe here an autosomally dominantly inherited
arrhythmic syndrome, the characteristics of which do not
fully match with any of the previously described disorders.
The hallmarks of this syndrome include exercise-induced
polymorphic ventricular tachycardia without gross or micro-
scopic alterations of the cardiac structures, delayed clinical
manifestation and a high mortality rate. We also demon-
strate that the underlying gene locus is tightly linked to
markers in chromosome 1q42–q43.
METHODS
Families. Two families with a total of 51 living members
were evaluated (Fig. 1). Six members died suddenly at
adolescence or early adulthood, and five patients were
evaluated because of an exercise-related syncope. A total of
43 members of these two families underwent cardiological
examination, including electrocardiographic (ECG) tests
and cardiac ultrasonography. Fourteen were considered to
be affected and subjected to further evaluation including
cardiac catheterization and angiography, electrophysiologic
testing and endomyocardial biopsy. All patients were oth-
erwise healthy and had no medications. Informed consent
was obtained from all patients and the study was carried out
in accordance with the Helsinki Declaration, approved by
the ethical review board.
Electrocardiographic and echocardiographic examina-
tions. Standard ECG was recorded at rest (50 mm/s, 0.1
mV/mm). QT interval was measured from lead II and
adjusted for heart rate (QTc) according to the Bazett’s
formula (12). QTc’s were compared to age- and gender-
matched healthy controls.
Bicycle ergometer test was performed with continuous
recording of leads II, aVF, V1–3,5. Maximum achieved load
and heart rate at which ventricular bigeminy first appeared
were recorded. QRS morphology was used to determine the
origin of ventricular arrhythmias according to criteria ob-
tained from ventricular tachycardia mapping (13).
Signal-averaged ECG was recorded (Marquette Elec-
tronics, Milwaukee, Wisconsin) using Frank XYZ leads and
a band pass filtering of 40 to 250 Hz. Simpson’s criteria
were applied for late potentials (14).
A 24-hour ambulatory ECG was recorded on an outpa-
tient basis. Mean heart rate, number of ventricular prema-
ture complexes and ventricular tachycardias ($3 consecutive
ventricular complexes) were calculated.
Acute effects of intravenous flecainide (2 mg/kg), a class
IC sodium channel blocking agent, were tested in four
Abbreviations and Acronyms
ARVD 5 arrhythmogenic right ventricular dysplasia
ECG 5 electrocardiogram, electrocardiographic
LQTS 5 long QT syndrome
MRI 5 magnetic resonance imaging
PCR 5 polymerase chain reaction
Figure 1. Pedigrees of Families 1 and 2. The empty circles/squares stand for unaffected women/men and the filled circles/squares for
affected women/men. The unaffected men carrying the disease haplotype is marked with an arrow. Individuals included in the linkage
study are indicated with circled numbers. SD 5 sudden death under the age of 35 years.
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patients to unmask the potential ECG abnormalities en-
countered in familial idiopathic ventricular fibrillation (Bru-
gada syndrome) (15,16). A 12-lead ECG was obtained prior
to, during and 15, 30, 60 and 120 min after the adminis-
tration of the flecainide.
Echocardiography with a 2.5 MHz transducer was per-
formed using parasternal long- and short-axis and apical
four-chamber views. Left ventricular dimensions and wall
thickness were measured from the M-mode recordings,
Doppler echocardiography was used to exclude any valvular
stenosis or regurgitation.
Phenotypic classification of family members. Patients
with frequent ventricular premature complexes (.10 per
min) or ventricular tachycardia during exercise stress test
were considered affected. Individuals ,18 years of age with
normal exercise stress test findings were classified as un-
known. Of the deceased family members, those whose
unexplainable death had occurred under the age of 30 years
were also considered affected.
Electrophysiologic testing, right ventricular cineangiog-
raphy and magnetic resonance imaging (MRI). Pro-
grammed ventricular stimulation was performed from the
right ventricular apex and outflow tract using two extra-
stimuli with and without infusion of epinephrine (50
mg/kg/min). Right ventriculography in 30° right and 60° left
anterior oblique views and coronary arteriography were
carried out in 11 adult affected subjects. Right ventricular
wall abnormalities were assessed according to Daliento (17),
and end-diastolic and end-systolic volumes were calculated
according to Ferlinz (18). Cineangiograms of 10 patients
with paroxysmal supraventricular tachycardia served as a
reference material in a blinded analysis by two cardiologists
independently. In addition, six patients underwent MRI.
The MRI heart studies were performed using a 1.5 Tesla
superconducting Siemens unit (Magnetom Vision, Sie-
mens, Erlangen, Germany), a phased-array body coil and
ECG triggering. T1-weighted spin echo axial and sagittal
images were used to analyze the right ventricular anterior
wall and a gradient-echo axial and sagittal cine sequence was
used to evaluate the possible right ventricular dyskinesia. A
breath-hold technique was combined to improve the image
quality.
Right ventricular endomyocardial biopsy. Right ventric-
ular endomyocardial biopsy specimens were obtained from
12 patients. Biopsies from patients less than six weeks after
heart transplantation and no signs of rejection or infection
were used for reference. Formalin-fixed, paraffin-embedded
tissue samples were stained with hematoxylin-eosin, van
Gieson and Masson’s trichrome. Extent of myocardial
fibrosis (van Gieson and Masson staining), lipid degenera-
tion, nuclear changes and interstitial inflammation were
scored blindly by two pathologists. Inflammation was con-
firmed by immunohistochemistry using a leukocyte com-
mon antigen monoclonal antibody (DAKO, Denmark).
Scores from 0 to 3, (0 indicating no and 3 advanced
changes) were used.
Statistical methods. Comparisons between groups were
performed with two-tailed Student t test for normally
distributed parameters or Mann-Whitney U test for non-
normally distributed parameters. Data are expressed as
mean 6 SD. A p value ,0.05 was considered significant.
Kaplan-Meier survival curves were constructed to assess the
cardiac event-free survival and mortality.
Genetic linkage studies. Nine affected and 16 unaffected
individuals from Family 1, and four affected and six unaf-
fected individuals from Family 2 were included in the
genetic linkage study (Fig. 1). Genomic DNA was extracted
from blood samples. Highly polymorphic microsatellite
markers from the Cooperative Human Linkage Center
(http://www.chlc.org), Ge´ne´thon (19), Genetic Location
Database (20) and Whitehead Institute (http://www.
genome.wi.mit.edu) databases were used in genotyping. The
31 markers used to scan chromosome 1 were approximately
evenly spaced with 10 cM intervals covering the whole
chromosome 1 (283 cM) and had a mean heterozygosity
index of 0.77.
Linkage analyses were performed with MLINK and
ILINK options of FASTLINK v. 3.0P package (21,22) and
GENEHUNTER (23). The MLINK was used for calcu-
lating the two-point lod scores at different recombination
fractions while the ILINK was used to define the maximal
likelihood estimate of theta. For pairwise lod score calcula-
tions, equal marker allele frequencies were assumed. The
multipoint scores were calculated for both parametric and
nonparametric linkage analysis with GENEHUNTER us-
ing allele frequencies from the data. A penetrance of 0.9 for
the disease and an affected allele frequency of 0.0002 were
assumed. Multipoint lod scores were calculated in “affected
only” mode in pedigree 1 while in two-point calculations the
whole pedigree was included. Power calculations were
performed using SIMLINK v. 4.11 (24,25).
Direct sequencing of a candidate gene TWIK-1. The
gene coding for the potassium channel TWIK-1 (human
two P-domain K1 channel) (26) was directly sequenced by
reverse transcriptase polymerase chain reaction (PCR) using
lymphocyte RNA as template. In brief, RNA was isolated
from fresh lymphocytes using RNAzolB (TEL-TEST,
Friendswood, Texas) and was transcribed to cDNA with
SuperScript™II Reverse Transcriptase (Gibco BRL, Life
Technologies, Paisley, United Kingdom). The PCR was
performed using cDNA as a template in standard condi-
tions.
RESULTS
Characteristics of the families. In two families, there were
14 subjects in total alive who exhibited exercise-induced
polymorphic ventricular arrhythmias. In addition, six family
members were considered affected because of sudden death
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at the age of 16 to 28 years; four of them had experienced
exercise- or anxiety-induced syncope prior to death. Au-
topsy findings were unremarkable in all six succumbed
individuals. Moreover, in the generation II of Family I,
there were four deceased obligate gene carriers (Fig. 1) who
had died at an average age of 48 6 9 years. Taken together,
a total of 24 individuals in these two pedigrees were
classified as affected (Fig. 1).
The clinical characteristics of the 14 living affected
individuals are summarized in Table 1. Nine of them had
experienced syncope associated with physical or emotional
stress. Their age at first symptoms was 21 6 10 years (range,
9 to 34 years). All children aged less than nine years were
asymptomatic.
Electrocardiography. Resting ECG indicated sinus
rhythm and normal atrioventricular conduction, QRS-
complex morphology, ST segment and T-wave pattern in all
patients. QTc intervals of the affected individuals (430 6
18 ms) were slightly longer than those of controls (409 6
19 ms, p , 0.01). Intravenous administration of flecainide
did not result in development of right bundle branch block
or ST segment elevation.
A total of 40 subjects were studied by exercise test. In 14
subjects, ventricular bigeminy appeared during exercise. In
eight patients arrhythmia progressed to nonsustained poly-
morphic ventricular tachycardia ($3 successive complexes)
which in one became sustained (Fig. 2, Table 2). The
average sinus rate at which the ventricular arrhythmias
initially appeared was 124 6 13 beats per min and arrhyth-
mias disappeared rapidly after discontinuation of exercise.
As judged by QRS morphology, ventricular arrhythmias
originated from both left and right sides of the heart in all
but one case.
The 24-h average heart rate in the ambulatory ECG
registrations was 70 6 5 beats per min. Three patients
exhibited nonsustained ventricular tachycardia while the
remaining had infrequent ventricular premature complexes
(Table 2). Three patients had nonsustained atrial tachycar-
dia. No disturbances of atrioventricular conduction were
observed. Two affected subjects had a late potential in
signal-averaged ECG. In the electrophysiologic study, ven-
tricular tachycardia was not inducible in any patient and
atrio-Hisian and His-ventricular intervals were normal (Ta-
ble 2).
Imaging studies. In echocardiography, the left ventricular
end-diastolic and end-systolic indexes were normal (Table
3). Interventricular septal and posterior wall thickness was
#11 mm in all patients. Right ventricular cineangiography
revealed no structural alterations or tricuspid valve insuffi-
ciency (Table 3). One patient had a 70% stenosis of the
descending left anterior coronary artery. In MRI study, the
structure of the myocardium was normal in all six studied
cases. No findings suggestive of right ventricular cavity or
outflow tract dilation or adipose replacement of the myo-
cardium were observed. Contraction of the right ventricle
was synergistic without signs of dyskinesia.
Figure 2. Left: Sample of the electrocardiogram of a 9-year-old
girl during the maximal load of the exercise stress test (leads II,
aVF, V2–5). Middle: Electrocardiogram of the same girl during
exercise stress test three years later showing multifocal ventricular
ectopic beats. Right: Electrocardiogram obtained during an exer-
cise stress test of a 42-year-old woman demonstrating sustained
polymorphic ventricular tachycardia (leads V1–6).
Table 1. Clinical Characteristics of the Affected Patients
Patients
(n 5 14) Range
Gender (men/women) 9/5
Age (yr) 33 6 15 12–51
Age at diagnosis (yr) 25 6 11 11–40
Follow-up time (yr) 8 6 6 4–20
No. of patients with
exercise-related syncope
9 (64%)
Table 2. Electrocardiographic Findings of Affected Patients
Variable Patients (n 5 14)
QT interval (ms) 430 6 18
Late potentials in signal-averaged
electrocardiogram (no. of
patients)
2
Ambulatory electrocardiographic
registration:
No. of patients with ventricular
tachycardia
3 (21%)
No. of patients with ventricular
bigeminy
3 (21%)
Exercise stress test:
Maximal heart rate achieved 164 6 26 (range 120–188)
Mean heart rate by appearance
of ventricular arrhythmias
121 6 15 (range 104–153)
No. of patients with
ventricular tachycardia
8 (57%)
No. of patients with
ventricular bigeminy
14 (100%)
Electrophysiological study:
Atrio-Hisian interval (ms) 80 6 21
His-ventricular interval (ms) 51 6 5
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Histopathological studies. Microscopic examination of
the endomyocardial biopsies showed no significant differ-
ences in the extent of fibrosis, adiposity, nuclear changes
and inflammation between patients and controls (Table 4).
Iron, Kongo and periodic acid-Schiff staining were negative
in all samples excluding relevant storage diseases.
Localization of the arrhythmogenic disorder to chromo-
some 1q42– q43. Linkage of the arrhythmic syndrome to
gene loci underlying the LQTS (KVLQT1, HERG and
SCN5A) as well as to the putative fourth gene in chromo-
some 4 (27–30) was excluded. Sequencing of the whole
coding sequence of the minK gene (31,32) revealed no
mutations (data not shown).
Highly polymorphic microsatellite markers, located ap-
proximately every 10 cM, were used in genotyping 24
members of Family 1, starting with chromosome 1. A
promising positive signal was obtained with the marker
D1S179. To assign the positive region more precisely, a
denser map including highly polymorphic markers both
centromeric (D1S2800) and telomeric (D1S235, ACTN2,
D1S2680, D1S2670, AFM214Xe11, D1S184) to D1S179
was used to type Families 1 and 2. When the results from
both pedigrees were combined, a maximal pairwise lod score
of 4.74 at theta 5 0 was revealed with the marker D1S2670
(Table 5), and a maximal multipoint lod score of 4.62, NPL
score of 17.10 and p value of 0.0005 were achieved with the
marker D1S2680 (Fig. 3). A lod score exceeding the value
3.0 was achieved in pedigree 1 alone (Zmax 5 4.13) but not
in the small pedigree 2 (Zmax 5 1.64) (Table 5). The
expected maximal (mean) lod scores based on simulation
calculations were 5.63 (2.48) for pedigree 1 and 2.07 (0.73)
for pedigree 2.
Recombinations between the disease and marker
D1S2800 were observed in pedigree 1 and in markers
D1S184 and AFM214Xe11 in both pedigrees, limiting the
disease locus telomeric of D1S2800 but centromeric of
AFM214xe11 (Table 6). The haplotype shared by all
affected subjects in pedigree 1 was 10-1-1-1-4 (D1S179-
D1S235-ACTN2-D1S2680-D1S2670) while the corre-
sponding haplotype in pedigree 2 was 6-1-1-5-3. One
unaffected individual (age 30 years) in pedigree 1 had
inherited the affected haplotype from his affected mother.
We hypothesized that this subject is a carrier of the mutant
gene and lack of symptoms is due to incomplete penetrance
of the gene. In conclusion, our data assigned the disease
locus between markers D1S2800 and AFM214xe11 in a
region of approximately 9 cM in size, close to the telomere
of chromosome 1 (1q42–q43).
Exclusion of TWIK-1 as a candidate gene by direct
sequencing. The chromosomal area 1q42–q43 contains a
putative candidate gene TWIK-1 (33) which is supposed to
be responsible for background potassium current in several
tissues and for phase IV in cardiac action potential. We
sequenced the entire coding region of the TWIK-1 gene;
however, no mutations or polymorphisms were identified
(data not shown).
Treatment, follow-up and mortality. Since the recogni-
tion of the inherited and malignant nature of the syndrome,
all affected patients with ventricular arrhythmias have been
on beta-adrenergic blocking therapy. During the average
treatment period of 8 6 6 years, one patient experienced an
episode of syncope and one cardiac arrest, later treated with
an implantable cardiac defibrillator. None of the children
aged less than 10 years showed any arrhythmias in their
ambulatory ECG recordings or exercise tests. However,
when reexamined up to four years after the first survey, three
children at the age of 11 to 13 years exhibited ventricular
arrhythmias on exercise test.
Kaplan-Meier curves for cumulative symptom free sur-
vival and mortality of all heterozygous carriers are indicated
in Figure 4. Considering the two families together, the
cumulative mortality by the age of 30 years was 31%.
DISCUSSION
We have characterized an arrhythmogenic cardiac disorder
which is inherited in an autosomal dominant fashion and
shows linkage to chromosome 1q42–q43 markers. The
patients suffer exercise-related syncope and sudden death.
The pathognomonic feature appeared to be a polymorphic,
exercise-induced ventricular tachycardia without evidence of
structural cardiac alterations. The QT interval may be
Table 3. Echocardiography and Right Ventricular
Cineangiography
Patients
(n 5 9)
Controls
(n 5 9)
Echocardiographic left ventricular:
End-diastolic diameter/BSA
(mm/m2)
28 6 3 29 6 4
End-systolic diameter/BSA
(mm/m2)
18 6 3 19 6 3
Posterior wall thickness (mm) 9 6 2 9 6 2
Interventricular septal thickness (mm) 10 6 2 9 6 1
Cineangiographic right ventricular:
End-diastolic volume/BSA (ml/m2) 89 6 15 93 6 29
End-systolic volume/BSA (ml/m2) 36 6 8 38 6 9
Ejection fraction (%) 41 6 4 42 6 6
BSA 5 body surface area. None of the parameters showed statistically significant
differences between groups.
Table 4. Histological Findings of Endomyocardial
Biopsy Samples
Patients
(n 5 10)
Controls
(n 5 10)
Fibrosis 1.21 1.00
Adipose tissue 0.39 0.54
Nuclear changes 1.02 0.79
Inflammation 0.06 0.29
None of the differences between the groups is statistically significant.
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slightly prolonged. The penetrance of the putative mutant
gene is high, and the syndrome shows significant mortality.
A large number of inherited cardiac disorders cause
arrhythmic sudden death. Many of these syndromes have
been assigned to specific chromosomal loci and, in some
cases, even the underlying genes have been cloned. These
malignant disorders include LQTS (4), ARVD (7–11),
Brugada syndrome (15), hypertrophic cardiomyopathy (34)
and dilated cardiomyopathies (35–43). The clinical, elec-
trophysiological and absent histopathologic characteristics
make the chromosome 1q42–q43 linked disorder different
from all the currently known syndromes.
The observed normality of cardiac structures suggests
pathogenetic mechanisms dissimilar to those in dilated or
hypertrophic cardiomyopathy. The normal average QTc
interval, the nature and age-dependent manifestation and
the chromosomal locus assigned to the syndrome are likely
to differentiate the arrhythmic disorder from the LQTS.
Finally, the absence of right bundle branch block and ST
segment elevation, even after provocative testing with so-
dium channel blocking agent flecainide, makes it distinct
from the Brugada syndrome which results from mutations
in cardiac sodium channel gene SCN5A (44).
Arrhythmias are seldom induced during exercise tests in
the LQTS but are frequently encountered in ARVD.
Indeed, exercise-induced ventricular tachycardia originating
from the right side of the heart is among the diagnostic
criteria of the disease (45). In striking contrast to ARVD,
our patients did not show T-wave abnormalities (6) or right
ventricular wall abnormalities as judged by cineangiography
and MRI, and the polymorphic appearance of the ventric-
Table 5. Multipoint LOD Score (LOD) at Theta 5 0 and Two-Point LOD Scores for Different Recombination Fractions for Eight
Different Markers of the Chromosome 1q42–q43
Marker Family
Multipoint
LOD
Two-Point LOD at Recombination Fraction
Thetamax Zmax0.00 0.05 0.10 0.20 0.30 0.40
D1S2800 1 2.52 20.04 0.13 0.22 0.27 0.23 0.14
2 1.64 1.59 1.42 1.24 0.84 0.48 0.14
total 4.16 1.54 1.55 1.46 1.14 0.71 0.28 0.03 1.56
D1S179 1 2.96 4.13 3.88 3.56 2.78 1.88 0.86
2 1.64 0.32 0.27 0.23 0.14 0.07 0.02
total 4.59 4.45 4.15 3.79 2.93 1.95 0.87 0.00 4.45
D1S235 1 2.97 1.97 1.76 1.53 1.06 0.60 0.21
2 1.64 20.14 20.11 20.08 20.04 20.02 0.00
total 4.61 1.84 1.65 1.45 1.02 0.58 0.20 0.00 1.84
ACTN2 1 2.98 3.38 3.08 2.76 2.08 1.35 0.56
2 1.64 0.95 0.87 0.78 0.58 0.34 0.11
total 4.62 4.34 3.95 3.54 2.66 1.69 0.67 0.00 4.34
D1S2680 1 2.98 0.14 0.22 0.25 0.23 0.17 0.09
2 1.64 1.64 1.47 1.29 0.92 0.52 0.16
total 4.62 1.78 1.68 1.54 1.15 0.69 0.24 0.00 1.78
D1S2670 1 2.94 3.36 3.27 3.06 2.46 1.67 0.75
2 1.64 1.38 1.23 1.07 0.74 0.40 0.11
total 4.58 4.74 4.50 4.14 3.20 2.08 0.86 0.00 4.74
AFM214XE11 1 2.83 20.24 20.14 20.08 20.02 20.01 20.01
2 1.47 20.14 20.11 20.08 20.04 20.02 0.00
total 4.29 20.38 20.25 20.16 20.07 20.03 20.01 0.66 0.02
D1S184 1 21.02 21.39 1.00 1.01 0.77 0.47 0.21
2 0.58 20.04 0.06 0.10 0.12 0.08 0.02
total 20.44 21.43 0.06 0.10 0.12 0.08 0.02 0.09 1.12
Figure 3. Lod scores calculated by GENEHUNTER for chromo-
some 1. The data are combined from pedigree 1 (38 markers) and
pedigree 2 (8 markers). The X-axis shows genetic markers using
the correct order and distances. The Y-axis shows the correspond-
ing lod scores. The highest peak is seen for marker D1S2680.
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ular tachycardia was clearly different from monomorphic
tachycardia with left bundle branch block pattern encoun-
tered in arrythmogenic right ventricular dysplasia (6). In
addition, right ventricular endomyocardial biopsies did not
show inflammatory (46) or degenerative changes (5,6,47)
typical of ARVD. Rare occurrence of late potentials (48)
and response to beta-adrenergic antagonists further empha-
sise the difference to ARVD.
A variant form of ARVD and later designated as ARVD2
characterized by occurrence of normal resting ECGs, effort-
induced polymorphic tachycardias and normal-sized right
ventricle was described by Nava and coworkers in a single
Italian family (49). As histological studies showed large
areas of fatty-fibrous replacement in the subepicardial layer
of the right ventricle, muscle-specific alpha-actinin genes
were considered likely candidates, and indeed, linkage of the
alpha-actinin ACTN2 gene to chromosome 1q42–q43 was
demonstrated in the family (7). At present, it is not possible
to exclude the possibility that the syndromes described by
Rampazzo et al. (7) and by us represent allelic although
different forms of the same underlying molecular pathology.
Another syndrome causing stress or emotion induced
syncope is the catecholaminergic polymorphic ventricular
tachycardia, first described in 1975 (50) and recently re-
viewed by Leenhardt et al. (51). In this syndrome any form
of increased adrenergic stimulation can induce polymorphic
ventricular premature complexes followed by bidirectional
and polymorphic tachycardia (51). A familial history of syn-
cope or sudden death is reported in 30% of cases. In distinction
to the disorder characterized by us, first symptoms occur before
the age of 10 years in the majority of the patients (51).
The consistent arousal of arrhythmias in the absence of
structural alterations in heterozygous carriers suggests a
cardiac electric disorder as an etiological mechanism. There-
fore, of the potential candidate genes for the inherited
polymorphic ventricular tachycardia, we sequenced the pro-
tein coding region of the TWIK-1 gene but failed to detect
any mutations or polymorphism. Another ion channel gene
of potential interest in chromosome 1q42–q43 is that
encoding the human cardiac muscle ryanodine receptor-
calcium release channel (Ryr-2) (52). This channel is a very
large protein which is located in the sarcoplasmic reticulum
and mediates the Ca21 efflux during the excitation-
contraction coupling in cardiac muscle.
Conclusions and clinical implications. Our data suggest
that a specific inherited form of human polymorphic ven-
tricular tachycardia mapped to chromosome 1q42–q43 is
distinct in its characteristics from other previously identified
hereditary arrhythmias. The possibility of this malignant
syndrome should not be ignored in cases with a positive
family history of syncope or sudden death but with no
structural cardiac abnormalities. In suspected cases, an
exercise stress test should be performed and even repeated,
if required, in adolescent cases. Since many inherited ar-
rhythmic disorders may present with only subtle abnormal-
ities and evade recognition, molecular genetic confirmation
of diagnosis will be of utmost importance.
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